ID

7727

Description

NSABP PROTOCOL B-38: Treatment Form for Group 1 - Doxorubicin, Cyclophosphamide, and Docetaxel (TAC) - Form T1 Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DD8782BC-197F-2A84-E034-0003BA12F5E7

Link

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DD8782BC-197F-2A84-E034-0003BA12F5E7

Keywords

  1. 12/18/14 12/18/14 - Martin Dugas
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 6/16/15 6/16/15 -
Uploaded on

January 9, 2015

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0 Legacy

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT00093795 Treatment - NSABP PROTOCOL B-38: Treatment Form for Group 1 - Doxorubicin, Cyclophosphamide, and Docetaxel (TAC) - Form T1 - 2284164v3.0

No Instruction available.

  1. StudyEvent: NSABP PROTOCOL B-38: Treatment Form for Group 1 - Doxorubicin, Cyclophosphamide, and Docetaxel (TAC) - Form T1
    1. No Instruction available.
Unnamed 1
Are data amended? (check box if yes, and circle amended items)
Unnamed 2
Agent Name
Was this cycle delayed due to adverse event(s)? (Circle Y or N for Yes, No)
Reason Treatment Ended (or Never Started Select only one)

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial